Company / Current Liabilities
Cytokinetics Current Liabilities History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$202.5M
FY2025
5-year range
$71.9M / $202.5M
FY2021-FY2025
Trend
+12.7%
vs FY2024
Sector context
#59 of 213
Health Care
What the data says
At $202M, Cytokinetics's current liabilities ranks #155 of 213 in the Health Care sector. Current Liabilities has increased for 7 consecutive years, from $22M in FY2018 to $202M in FY2025.
Based on SEC 10-K filings.
$202M in FY2025 with a 5-year CAGR of +45.4%.
Increased from $103M to $202M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +33.7%
- 5-Year CAGR
- +45.4%
- 10-Year CAGR
- -
Sector benchmark
#155 of 213 in Health CareTop 72% of 213This company $202.5M Sector average $1.6B
▼
-87.3% below sector average
Key checks
Key Insights
- Cytokinetics's current liabilities has grown for 7 consecutive years.
- 5-year CAGR of +45.4%, indicating consistent growth.
- In FY2025, current liabilities increased 12.7% year-over-year.
- Ranks #59 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.12 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $202.5M | +12.7% |
| FY2024 | $179.7M | +75.0% |
| FY2023 | $102.7M | +21.3% |
| FY2022 | $84.6M | +17.8% |
| FY2021 | $71.9M | +130.3% |
| FY2020 | $31.2M | +19.9% |
| FY2019 | $26.0M | +17.3% |
| FY2018 | $22.2M | -31.6% |
| FY2017 | $32.4M | -2.4% |
| FY2016 | $33.3M | +5.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026